Email Newsletters

Marlborough

Oxford Immunotec plans to bring its research-use COVID test to South Korea

Oxford Immunotec, a diagnostics company based in both Marlborough and the United Kingdom, has entered a memorandum of understanding to bring its research-use-only T-SPOT Discovery SARS-CoV-2 to South Korea.

Boston Scientific, Hanover Insurance make LGBTQ equality list

Marlborough's Boston Scientific and Worcester's Hanover Insurance Group are among 767 companies nationwide lauded for LGBTQ equality.

Boston Scientific sales down $822M in 2020

Marlborough medical device company Boston Scientific reported a net sales decline of $822 million in 2020, with losses across the board accounting for a 7.7% drop from 2019’s sales.

Hologic breast surgery device affirmed by study

A new study has demonstrated the safety and clinical effectiveness of a device Hologic is developing to aid with breast surgery.
ADVERTISEMENT

Hologic teams up with Google Cloud to enhance cervical cancer detection

Marlborough medical device company Hologic will soon integrate Google Cloud’s machine learning technologies into its Genius Digital Diagnostics system, which helps doctors screen for cervical cancer, Hologic announced on Monday.

Marlborough, Lowell adult day health centers fined $1M over billing

Two adult day health centers, both owned by Malay Patel of Lowell, will pay out a cumulative $1,060,957 to settle allegations they improperly billed MassHealth for their services since 2014, Attorney General Maura Healey announced on Thursday.

Marlborough biosciences software firm raises $5M

Marlborough’s Scitara Co. announced today it has closed $5 million in a Series A round of funding.

Hologic profits $1.2B in three months, on strength of COVID tests

Marlborough medical technology device company Hologic announced on Tuesday a nearly 90% increase in revenue in the first quarter of 2021, resulting in $1.18 billion in gross profit.
ADVERTISEMENT

FDA approves Boston Scientific’s Parkinson’s brain stimulation system

Marlborough medical device company Boston Scientific’s fourth generation Vercise Genus Deep Brain Stimulation System has received FDA approval, the company announced on Friday.

🔒Coworking centers adapt to the pandemic and look to regain growth

Coworking spaces and the coronavirus pandemic were never going to be a great match.
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA